These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 28569236

  • 1. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
    LaForce CF, Carr W, Tilles SA, Chipps BE, Storms W, Meltzer EO, Edwards M.
    Allergy Rhinol (Providence); 2010 Apr 01; 1(2):14. PubMed ID: 28569236
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
    LaForce CF, Carr W, Tilles SA, Chipps BE, Storms W, Meltzer EO, Edwards M.
    Allergy Asthma Proc; 2010 Apr 01; 31(2):132-40. PubMed ID: 20302683
    [Abstract] [Full Text] [Related]

  • 3. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan 01; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 4. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
    Lieberman P, Meltzer EO, LaForce CF, Darter AL, Tort MJ.
    Allergy Asthma Proc; 2011 Jan 01; 32(2):151-8. PubMed ID: 21352639
    [Abstract] [Full Text] [Related]

  • 5. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.
    Allergy Asthma Proc; 2012 Jan 01; 33(6):450-8. PubMed ID: 23127291
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI, Edin AS, Astafieva NG, Lopatin AS, Sidorenko IV, Ukhanova OP, Khanova FM.
    Int Arch Allergy Immunol; 2019 Jan 01; 178(3):255-263. PubMed ID: 30677766
    [Abstract] [Full Text] [Related]

  • 7. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
    Kaliner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, Lanier BQ, Chipps B.
    Allergy Asthma Proc; 2009 Jan 01; 30(3):255-62. PubMed ID: 19549426
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
    Berger WE, Ratner PH, Casale TB, Meltzer EO, Wall GM.
    Allergy Asthma Proc; 2009 Jan 01; 30(6):612-23. PubMed ID: 20031007
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.
    Ratner PH, Hampel FC, Amar NJ, van Bavel JH, Mohar D, Marple BF, Roland PS, Wall GM, Brubaker MJ, Drake M, Turner D, Silver LH.
    Ann Allergy Asthma Immunol; 2005 Nov 01; 95(5):474-9. PubMed ID: 16312171
    [Abstract] [Full Text] [Related]

  • 10. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
    Hampel FC, Pedinoff AJ, Jacobs RL, Caracta CF, Tantry SK.
    Allergy Asthma Proc; 2019 Jul 03; 40(4):261-272. PubMed ID: 31053180
    [Abstract] [Full Text] [Related]

  • 11. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W.
    Allergy Asthma Proc; 2012 Jul 03; 33(4):324-32. PubMed ID: 22856633
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
    Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, Finn AF, Marple BF, Roland PS, Wall GM, Brubaker MJ, Dimas C, Potts SL, Silver LH, Barnes JR.
    Ann Allergy Asthma Immunol; 2005 Dec 03; 95(6):600-6. PubMed ID: 16400902
    [Abstract] [Full Text] [Related]

  • 13. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
    Patel D, Garadi R, Brubaker M, Conroy JP, Kaji Y, Crenshaw K, Whitling A, Wall GM.
    Allergy Asthma Proc; 2007 Dec 03; 28(5):592-9. PubMed ID: 18034980
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan 03; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis.
    Andrews CP, Mohar D, Salhi Y, Tantry SK.
    Ann Allergy Asthma Immunol; 2020 Feb 03; 124(2):171-178.e2. PubMed ID: 31734334
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May 03; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
    Meltzer EO, Garadi R, Laforce C, Chadwick SJ, Berger WE, Gross G, Edwards MR, Crenshaw K, Wall GM.
    Allergy Asthma Proc; 2008 May 03; 29(6):659-68. PubMed ID: 19144261
    [Abstract] [Full Text] [Related]

  • 18. Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study.
    Fifer S, Toh L, Barkate H, Aggarwal V, Borade D, Gordonsmith RH, Wu W, Morgan C, Young K.
    Patient Prefer Adherence; 2023 May 03; 17():141-151. PubMed ID: 36687019
    [Abstract] [Full Text] [Related]

  • 19. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
    Berger WE, Fineman SM, Lieberman P, Miles RM.
    Ann Allergy Asthma Immunol; 1999 Jun 03; 82(6):535-41. PubMed ID: 10400480
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis.
    Gross GN, Berman G, Amar NJ, Caracta CF, Tantry SK.
    Ann Allergy Asthma Immunol; 2019 Jun 03; 122(6):630-638.e3. PubMed ID: 30910440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.